Researcher.Life Logo

Infection and Drug Resistance : Impact Factor & More

eISSN: 1178-6973pISSN: 1178-6973
JournalOpen Access

Key Metrics

CiteScore
5.6
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
Scite Index
0.79 5-Year SI
SJR
Q2Pharmacology
SNIP
1.37
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Infection and Drug Resistance

Infection and Drug Resistance Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Infection and Drug Resistance ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Infection and Drug Resistance

Safety and Efficacy of Nebulized Inhalation of Polymyxin B Sulfate for Carbapenem-Resistant Gram-Negative Bacterial Pneumonia: A Multi-Center, Prospective, Observational Study
  • 14 May 2026
  • Infection and Drug Resistance
The HIV/HBV Co\u2011infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter]
  • 14 May 2026
  • Infection and Drug Resistance
Clonal Expansion of penA-60.001 in Cephalosporin-Resistant Neisseria gonorrhoeae: A Molecular Epidemiology Study in Meizhou, China, 2020\u20132024
  • 13 May 2026
  • Infection and Drug Resistance
Thrombosis in Severe Influenza A Pneumonia: Distribution and Risk Factors in Hangzhou, China
  • 13 May 2026
  • Infection and Drug Resistance
Molecular Epidemiology of Pediatric Respiratory Infections in Xinjiang, China: A Cross-Sectional Study of Six Pathogens
  • 13 May 2026
  • Infection and Drug Resistance
Strategies for Managing Marburg Virus Disease Outbreaks: Lessons from the Rwanda Outbreak
  • 13 May 2026
  • Infection and Drug Resistance
Safety and Efficacy of Nebulized Inhalation of Polymyxin B Sulfate for Carbapenem-Resistant Gram-Negative Bacterial Pneumonia: A Multi-Center, Prospective, Observational Study
  • 14 May 2026
  • Infection and Drug Resistance
The HIV/HBV Co\u2011infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter]
  • 14 May 2026
  • Infection and Drug Resistance
Clonal Expansion of penA-60.001 in Cephalosporin-Resistant Neisseria gonorrhoeae: A Molecular Epidemiology Study in Meizhou, China, 2020\u20132024
  • 13 May 2026
  • Infection and Drug Resistance
Thrombosis in Severe Influenza A Pneumonia: Distribution and Risk Factors in Hangzhou, China
  • 13 May 2026
  • Infection and Drug Resistance
Molecular Epidemiology of Pediatric Respiratory Infections in Xinjiang, China: A Cross-Sectional Study of Six Pathogens
  • 13 May 2026
  • Infection and Drug Resistance
Strategies for Managing Marburg Virus Disease Outbreaks: Lessons from the Rwanda Outbreak
  • 13 May 2026
  • Infection and Drug Resistance

FAQs on Infection and Drug Resistance